Schizophrenia Bulletin vol. 44 no. 2 pp. 463, 2018 doi:10.1093/schbul/sbx193 ERRATUM Erratum to: Devoe DJ, Peterson A, Addington J. Negative any negative symptom treatment. Many studies had small Symptom Interventions in Youth at Risk of Psychosis: samples and the majority were not designed to target neg- A Systematic Review and Network Meta-Analysis. ative symptoms.” Schizophr Bull. doi:10.1093/schbul/sbx139 Page 9, line 18/19: Delete “…demonstrated small to The authors regret that, although the text is clear that large effect sizes for negative symptom reduction com- neither efficacy nor effectiveness was statistically con- pared to ….” and replace with: “…ranked ahead of….”. firmed for any of the examined treatments, the abstract Page 9: Delete the last sentence of the NMDAR and text contained a mis-statement regarding effective- Modulators section line 33 and replace with: “Lastly, ness when rank ordering treatments according to the net- SUCRA plots of the absolute effects and rank test among work analysis. the 11 treatments indicated that NMDAR modulators Page 1: In the Abstract under Results, Add “The null ranked higher than the other 10 treatments, but this is hypothesis was not rejected for any of the 11 treatments” in the context of no statistically supported efficacy com- between the first sentence “Of 3,027…. participants.” pared to placebo.” and the second sentence “Only N-methyl-D-aspartate- Page 13: In the Conclusions of the main text the first receptor (NMDAR) modulators trended towards a signifi- sentence should be deleted and replaced with the follow- cant reduction in negative symptoms compared to placebo ing: “In conclusion, this review contained information on (SMD,-0.54, 95%CI, -1.09 to 0.02; I = 0%, P = 0.06).” clinical trials of 11 treatment approaches. Support for ef- Page 1: In the Conclusion of the Abstract current word- ficacy or effectiveness did not reach statistical significance ing should be deleted and the conclusions should now for any of the treatments. Many of the relevant studies read: “Efficacy and effectiveness were not confirmed for had small samples…”. © The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: firstname.lastname@example.org Downloaded from https://academic.oup.com/schizophreniabulletin/article-abstract/44/2/463/4860201 by Ed 'DeepDyve' Gillespie user on 16 March 2018
Schizophrenia Bulletin – Oxford University Press
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera